Upcoming Events

2018 Annual Meeting of Stockholders

Dec 21, 2018 • 10:00am PST

View All Events

Latest Financial Results

Q3 2018

Quarter Ended Sep 30, 2018

Stock Information

Company Overview

HJLI specializes in developing and manufacturing bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has three product candidates: the porcine tissue based VenoValve®, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency; the CoreoGraft®, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery, and a porcine tissue based heart valve, which based upon its relatively small size and increased output, is an ideal candidate for pediatric aortic/mitral valve replacement.

Investor Presentation

Investor Presentation

Click Here Investor Presentation


Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information


Hancock Jaffe Laboratories, Inc.
70 Doppler
Irvine, CA 92618
T: 949-261-2900
F: 949-261-2992

Investor Relations

Robert A Berman
T: 949 261-2900

Transfer Agent

V Stock Transfer LLC